Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection

BMC Infect Dis. 2020 Jan 28;20(1):79. doi: 10.1186/s12879-019-4750-4.

Abstract

Background: Mycoplasma pneumoniae is one of the most common causative pathogens of community-acquired pneumonia (CAP), accounting for as many as 30-50% of CAP during peak years. An early and rapid diagnostic method is key for guiding clinicians in their choice of antibiotics.

Methods: The recombinase-aided amplification (RAA) assay is a recently developed, rapid detection method that has been used for the detection of several pathogens. The assays were performed in a one-step single tube reaction at 39° Celsius within 15-30 min. In this study, we established an RAA assay for M. pneumoniae using clinical specimens for validation and commercial real-time PCR as the reference method.

Results: The analytical sensitivity of the RAA assay was 2.23 copies per reaction, and no cross-reactions with any of the other 15 related respiratory bacterial pathogens were observed. Compared with the commercial real-time PCR assay used when testing 311 respiratory specimens, the RAA assay obtained 100% sensitivity and 100% specificity with a kappa value of 1.

Conclusions: These results demonstrate that the proposed RAA assay will be of benefit as a faster, sensitive, and specific alternative tool for the detection of M. pneumoniae.

Keywords: Detection; Molecular diagnostic technique; Mycoplasma pneumoniae; Recombinase; Recombinase-aided amplification.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Community-Acquired Infections / microbiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mycoplasma pneumoniae / genetics*
  • Nucleic Acid Amplification Techniques / methods*
  • Pneumonia, Mycoplasma / microbiology*
  • Recombinases / genetics*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Recombinases